Irritable Bowel Syndrome News

Salix Pharmaceuticals recently released survey results in a report, Patient Perspectives: Living with IBS in a Pandemic, offering perspectives from adults with irritable bowel syndrome during the COVID-19 pandemic.

Irritable bowel syndrome is one of the most burdensome and chronic ailments with an estimated 45 million people affected in the United States, the International Foundation for Gastrointestinal Disorders reports.

In this episode, Brian E. Lacy, MD, PhD, joins us to discuss the American College of Gastroenterology’s newest guidelines for irritable bowel syndrome, options for patients with IBS-D and IBS-C, and much more.

Opioid prescriptions rates for gastrointestinal conditions continue to increase, with renewals of existing prescriptions being the main driver, according to a study in the American Journal of Gastroenterology.

Researchers found that specific foods and nutrients correlated with species known to have mucosal protection and anti-inflammatory effects, according to data published in Gut.

In this exclusive video, Monia Werlang, MD, discusses the role gastroenterologists have in identifying and treating patients with eating disorders.

Patients with constipation-predominant irritable bowel syndrome treated with a delayed-release version of linaclotide experienced improvements in abdominal pain, according to study results.

A short-term strict low FODMAP diet and long-term ‘modified’ low FODMAP diet was linked to improvements in symptoms and quality of life in irritable bowel syndrome-diarrhea predominant patients, according to study results.

A presentation at the Crohn’s and Colitis Congress, highlighted recent updates on dietary therapy for inflammatory bowel disease.

In this episode, Douglas A. Drossman, MD, joins us to discuss his path into medicine, the history and influence of brain-gut interactions and what gastroenterologists can expect for Rome V criteria.